When the drug orismilast comes to China, the biotech company Union Therapeutics, headquartered in Denmark, will collaborate with Innovent Biologics, informs the Danish company in a press release.
The statement reads that the two companies have entered into a strategic collaboration and license agreement with the Chinese company, which gives Innovent Biologics exclusive rights to the research, development and commercialization of orismilast in China, including Hong Kong, Macau and Taiwan. The agreement also means that Chinese patients will be included in any future global studies of the drug.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Long wait for IVDR implementation is over, putting an end to pandemic "wild west"
After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Bavarian Nordic upgrades guidance following vaccine contract
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
Biomarker Operations Lead 
Account Manager 
Clinical Trial Manager 
Senior IT Network Engineer 
Biostatistician 
Senior Manager, Clinical Trial Budget 
Nordic Medical Affairs Manager 
Consultant Manager 
Client Talent Acquisition Specialist 
Project Manager & Scrum Master 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Innovation Project Manager, Display Unit 
Director for innovative pre-clinical testing unit 
Production Director 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Director Global Engineering 
System Sales Development Consultant - Investment Projects, Merck Millipore